BioAge Labs (BIOA)

• Market cap: $900M
• 1 day: 15.12%
• 5 days: 5.79%
• 1 month: 9.78%
• 3 months: 72.26%
• 6 months: 339.8%
• Year to date: 67.97%
• 1 year: 396.54%
• 5 years: 17.7%
• 10 years: 17.7%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Employees: 64